Drug factory · FDA FEI 3002807632

Moehs Catalana SL

Calle Cesar Martinell I Brunet, 12-A (PG IND RUBI SUR), Rubi, Spain

Spain: 1

Problems found, fixed voluntarily at FDA's last inspection, Nov 10, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

6 drug inspections on record since 2010: 0 with no problems, 6 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
MetoprololMakes the active ingredient Cipla USA., Inc. 69097-407, 69097-408, 69097-409

FDA inspection history

EndedResultProgramProblems noted
Nov 10, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
May 18, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 22, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 26, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
May 9, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 12, 2010Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: api manufacture.